IPO: Eris Lifesciences Limited

ErisEris Lifesciences ipo

♦ ISSUE PERIOD : 16th June 2017 to 20th June 2017
♦ PRICE RANGE: Rs 600 to Rs 603
♦ Lot Size: 24 Shares
♦ Issue Size: 28,875,000 Shares


Eris Lifesciences Limited developes, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology;
and anti-infectives. Their focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders. The chronic category of the IPM contributed 65.6% of their revenues in Fiscal 2017 (Source: IMS TSA MAT, March 2017). Eris Lifesciences Limited were ranked 20th out of 377 domestic and multinational companies present in the chronic category of the IPM, in terms of revenues for Fiscal 2017 (Source: IMS TSA MAT, March 2017). Eris Lifesciences Limited were the fastest growing company, in the chronic category, among the top 25 companies in terms of
revenues, with revenue growth at CAGR of 28.9%, between Fiscals 2013 and 2017 (Source: IMS TSA MAT, March, 2017). Eris Lifesciences Limited generated 34.4% of their revenues from the acute category of the IPM in Fiscal 2017. their revenues from the acute category grew at a CAGR of 12.0% between Fiscals 2013 and 2017 (Source: IMS TSA MAT, March 2017).

Source: DRHP

Are you fed-up with high brokerage charges??
Invest in IPOs and Stocks at ZERO brokerage!!! 


Symbol ERIS
Issue Period 16-Jun-2017 to 20-Jun-2017
Post issue Modification Period 21-Jun-2017 (10.00 A.M. to 1.00 P.M.)
Issue Size Initial Public Offering of up to 28,875,000 Equity Shares (including anchor portion of 12,926,250Equity Shares)
Issue Type 100% Book Building
Discount Rs 60 per Equity Share for Eligible Employee category only
Price Range Rs 600 to Rs 603
Face Value Re 1
Tick Size Re 1
Bid Lot 24 Equity Shares and in multiples thereof
Minimum Order Quantity 24 Equity Shares
Maximum Bid Quantity 1,59,48,744 Equity Share
Maximum Subscription Amount for Retail Investor Rs. 2,00,000
IPO Market Timings 10.00 a.m. to 5.00 p.m.
Book Running Lead Managers Axis Capital Limited, Citigroup Global Markets India Private Limited and Credit Suisse Securities (India) Private Limited
Categories FI, IC, MF, FII, OTH, CO, IND, NOH and EMP
Name of the Registrar Link Intime India Private Limited
Address of the Registrar C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai 400 083, Maharashtra, India
Contact person name number and Email id Ms. Shanti Gopalkrishnan, +91 22 4918 6200, eris.ipo@linkintime.co.in

Source: NSE

Stop paying high brokerage!!
Pay ZERO brokerage for IPOs

Popular articles: